Skip to Main Content

Paper Details

Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction.
J Am Coll Cardiol
21
2023
Cardiomyopathy, Dapagliflozin, HF, HFmrEF, HFpEF, Heart Failure, Patients, cardiovascular, dapagliflozin, heart failure, heart failure with preserved ejection, patients
Author NameAffiliation
Mikhail KosiborodSaint Luke's Mid America Heart Institute and University of Missouri-Kansas City
Carolyn S P LamNational Heart Centre Singapore and Duke-National University of Singapore
Adrian F HernandezDuke University Medical Center
Rudolf A de BoerUniversity of Groningen, University, Medical Center Groningen
Akshay S DesaiBrigham and Women's Hospital, Harvard Medical School
  • 1 - 5

Datasets

Release 1.2